SABCS18 5 Key Highlights
Last month BCRF attended the 41st Annual San Antonio Breast Cancer Symposium (SABCS), the largest annual breast cancer meeting in the world. This year’s meeting breast cancer symposium more than 7,500 attendees from 90 countries.
How patients have transformed a medical meeting about breast cancer
Advocates have become an essential part of the annual San Antonio Breast Cancer Symposium, an influential medical meeting. Former oncologist Elaine Schattner explains the change and its importance.
Ann Loeser’s SABCS18 Summary
Pacific Northwest Metastatic Conference
An overview of the third annual Northwest Metastatic and Lobular Breast Cancer Conference, held Oct. 26-27 in Seattle.
Elaine Schattner on TailorX
These results have the potential to reduce overtreatment of breast cancer—stopping patients’ unnecessary exposure to chemotherapy—in a large fraction of cases. The public health implications are huge.
Dr. Attai ASCO2018 TailorX Study Results
Results of the TailoRx study, which provides some much-needed clarification on which breast cancer patients benefit from chemotherapy.
Dr. Attai Highlights from the 2018 American Society of Breast Surgeons Annual Meeting
TailorX Article in Vogue
An influential new study finds many women with early-stage breast cancer can now avoid chemotherapy—safely and effectively.
ASCO2018 Sacituzumab Data for Heavily Pretreated MBC
ASCO2018 Taselisib with Faslodex for MBC
Results from a Phase lll clinical trial demonstrate the success of a new targeted medicine, taselisib, in treating advanced breast cancer.
2018/05/30 HER2+ Combo of pertuzumab-trastuzumab-capecitabine prolongs survival
Although progression-free survival was not significantly increased, long-term overall survival may be improved with pertuzumab.